BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 13, 2008
View Archived Issues
Recent patent literature discloses novel antibacterial agents
Read More
New therapeutic agents for obesity and other metabolic disorders described in recent patents
Read More
Novel therapeutic agents for HIV infection reported in a recent patent
Read More
Maruzen imparts novel agents for dermatological disorders in a recent patent
Read More
Experiments clarify antidepressant activity of ketamine
Read More
Significant antimanic effects observed with tamoxifen in a randomized trial
Read More
FDA accepts Pipex's IND application to conduct phase II clinical trial of oral flupirtine
Read More
Nventa initiates dosing in final cohort of phase I trial of HspE7
Read More
iCo Therapeutics presents a clinical update on human monoclonal antibody iCo-008
Read More
Anavex reports results from preclinical studies of cancer drug Anavex 7-1037
Read More
Symbollon signs term sheet to acquire MedPharm for USD 1.5 million
Read More
EUSA Pharma to acquire Cytogen for USD 22.6 million in cash
Read More
EMEA grants Clinuvel two orphan drug designations for CUV-1647
Read More
Percutaneous Loxonin Tape receives Japanese marketing approval
Read More
Novartis submits Rasilez for approval in Japan
Read More
CRx-191 demonstrates positive phase II results in psoriasis
Read More
Nymox reports results from U.S. NX-1207 study in benign prostatic hyperplasia
Read More
XenoPort presents positive phase I results with XP-21279
Read More
Bionovo reports support for MF-101 from two independent physician surveys
Read More
Ortho Biotech to defend the safety of Procrit and ESAs at meeting with the ODAC
Read More
Avicena's HD-02 to enter NIH-sponsored phase III trial in HD
Read More
Calistoga Pharmaceuticals begins first clinical trial of novel oral PI3K delta inhibitor
Read More
FDA accepts Arisaph's IND application to evaluate ARI-2243 in phase I clinical trial
Read More